Home / 2012 (page 81)

Yearly Archives: 2012

GLP-1: Actions on Beta-cell Mass and Function

632_Fig1

David Joffe, BSPharm, CDE Tina Burge, PharmD Candidate Florida A&M University Kiet Ngo, Pharm D Candidate Mercer University Abnormalities in incretin hormones such as the glucagon-like peptide-1 (GLP-1) contribute to the development of hyperglycemia. GLP-1 was discovered as a peptide encoded by the proglucagon gene and was named glucagon-like because …

Read More »

FDA Approves New Weight-Loss Drug

FDA Approves New Weight-Loss Drug The oral weight-loss drug lorcaserin hydrochloride (Belviq) has been approved as an adjunct to diet and exercise in obese patients as well as in those who are overweight and have at least one other weight-related disorder such as hypertension. See this week’s Item #2, FDA …

Read More »

The influence of diabetes on the periodontal tissues

Maria Emanuel Ryan, DDS, PhD; Oana Carnu, DMD; Angela Kamer, DMD, PhD The pathogenesis of periodontal disease is complex because it reflects a combination of the initiation and maintenance of the chronic inflammatory process by a diverse microbial flora and its numerous bacterial products. The subsequent host response to this infection mediates …

Read More »

Editor’s Desk: More on ADA-EASD Guidelines

Over the past four weeks we have shared some fantastic Homerun Slides on the new ADA-EASD guidelines for diabetes care. This week, Dr. Richard S. Beaser from the Joslin Diabetes Center provides more details on the guidelines and their history — be sure to read his comments in this week’s …

Read More »